These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27836331)

  • 1. Subsequent vitiligo after hematopoietic stem cell transplantation: A nationwide population-based cohort study from Korea.
    Bae JM; Choi KH; Jung HM; Kim SY; Kim M; Kim GM; Yu DS; Lee YB
    J Am Acad Dermatol; 2017 Mar; 76(3):459-463. PubMed ID: 27836331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
    Bang CH; Park HE; Kim YH; Jung JH; Lee JH; Park YM; Han JH
    JAMA Dermatol; 2024 Feb; 160(2):194-198. PubMed ID: 38091023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
    Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.
    Fan WC; Liu CJ; Hong YC; Feng JY; Su WJ; Chien SH; Chen TJ; Chiang CH
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):58-64. PubMed ID: 25519791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
    Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Minakawa K; Tanosaki R
    Transfusion; 2020 May; 60(5):1015-1023. PubMed ID: 32306410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation.
    Zhang XH; Feng FE; Han W; Wang FR; Wang JZ; Wang Y; Chen Y; Fu HX; Mo XD; Zhang YY; Yan CH; Chen H; Chen YH; Liu Y; Xu LP; Liu KY; Huang XJ
    Thromb Res; 2016 Aug; 144():6-11. PubMed ID: 27261538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children.
    Huang JT; Song JS; Hawryluk EB; London WB; Guo D; Sridharan M; Fisher DE; Lehmann LE; Duncan CN
    J Am Acad Dermatol; 2018 Aug; 79(2):230-237. PubMed ID: 29588248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
    Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
    J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of osteoporosis and pathologic fractures in cancer patients who underwent hematopoietic stem cell transplantation: a nationwide retrospective cohort study.
    Lin JN; Chen HJ; Yang CH; Lai CH; Lin HH; Chang CS; Liang JA
    Oncotarget; 2017 May; 8(21):34811-34819. PubMed ID: 28422731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
    Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors of graft-versus-host disease in patients after allogeneic stem cell transplantation].
    Kozak I; Dwilewicz-Trojaczek J; Siemińska J; Górska R
    Wiad Lek; 2011; 64(3):164-9. PubMed ID: 22335138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on chronic health conditions and its related risk factors in recipients after hematopoietic stem cell transplantation].
    Song JJ; Ren HY; Qiu ZX; Wang MJ; Xu WL; Liu W; Li Y; Dong YJ; Yin Y; Sun YH; Wang LH; Ou JP; Wang WS; Cen XN
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):615-8. PubMed ID: 23134852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
    Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
    Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
    Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
    Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Hu Y; Zhang XH; Wang YZ; Mo XD; Zhang YY; Wang Y; Han W; Xu LP; Chang YJ; Huang XJ
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1190-7. PubMed ID: 24792870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.